Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:PFE

Pfizer Inc (PFE)

26.17
+0.57 (2.23%)
as of Jun 11, 2026, 8:00:00 pm Market Open.
322 watching
0
TOP PICK
One of the premier drug companies in the world. Good dividend. Generates a lot of cash. Have 20 new drugs that they'll be releasing. Good price.
DON'T BUY
This stock and Merk are not acting well. Some talk of downward earning revisions. Seeing pressures on high drug prices.
BUY ON WEAKNESS
Has a big portfolio of drugs. Buying under $30. Trading at a significant discount to the market. Profit margins are shrinking because of government pressures because of deficits. Competition from generic drugs.
DON'T BUY
In a decline in the charts.
BUY
Likes the company at these levels. Their recent merger will create growth. There should be 13/14% growth in earnings over the next couple of years.
BUY
Pharmaceutical stocks are defensive in nature.In this environment, nobody's buying them.Will be dead money in the short term.The strongest of the drug companies and the deepest pipeline.A good price to buy out for the long-term.
PAST TOP PICK
(A top pick July 23/03.Down 4 «%.)Drug companies , stocks have dropped because they think of concerns on drug pricing.Longer-term demographically Phizer is very well-positioned.It represents great long-term value.
DON'T BUY
Model price is around $29.Prefers Merk.Too expensive.
BUY
Likes this company.Valuation is more attractive than what it has been for some time.Generating growth, and very little risk in the stock.
HOLD
Good company. Pharmaceutical group is reasonably well priced. Compatition is coming into their core product line.
TOP PICK
15/25% earnings growth for the next 3/5 years. High quality.
DON'T BUY
Ethical drug companies are not doing well at this time.
WEAK BUY
Has the deepest and broadest portfolio of any drug company. 20 drugs under development. Growth may be limited.
TOP PICK
Has a huge pipeline. PE is at a reasonable level. Good dividends and they are increasing.
TOP PICK
Fair market value is excellant. Investors like drug stocks.
Showing 676 to 690 of 801 entries